Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1078

SHR1210-hIgG1

Home » SHR1210-hIgG1

Background of SHR1210-hIgG1

SHR-1210 is a monoclonal antibody directed against programmed cell death 1 (PD-1), a protein found on the surface of specialized immune system cells called T-cells. When bound to its ligand, the programmed cell death ligand 1 (PD-L1), PD-1 suppresses the immune function of T-cells to ensure that they do not mistakenly attack healthy cells.

Specifications

Catalog Number:
KB-1078
Antibody Name:
SHR1210-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Wild Type
Target:
PD1
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, et al Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 2015;13:194–227.
  2. Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology 2015;149:1700–15.
  3. Huang J, Zhou Y, Zhang H, Qu T, Mao Y, Zhu H, et al A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy. Med Oncol 2013;30:343.